Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thatcher

Showing results (211-220 of 289) with videos related to

Pageof 29
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Viridans streptococcal bacteraemia in patients with haematological and solid malignanciesA D Burden, B A Oppenheim, D Crowther, et al.
Melanoma Research|April 4, 2002
Effect of temozolomide on central nervous system relapse in patients with advanced melanomaM J Paul, Y Summers, A H Calvert, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 9, 2003
A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancerH J Mackay, M O'Brien, S Hill, et al.
Lancet (London, England)|May 8, 1982
11-week course of sequential methotrexate, thoracic irradiation, and moderate-dose cyclophosphamide for "limited"-stage small-cell bronchogenic carcinoma. A study from the Manchester Lung Tumour GroupN Thatcher, P V Barber, R D Hunter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseaseN Thatcher, H Sharma, R Harrison, et al.
Cancer Treatment Reports|April 1, 1985
Activity of JM9 in advanced ovarian cancer: a phase I-II trialV H Bramwell, D Crowther, S O'Malley, et al.
British Journal of Cancer|February 1, 1996
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancerD C Betticher, J Heighway, P S Hasleton, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosisA G Kamthan, M J Lind, N Thatcher, et al.
European Journal of Nuclear Medicine|January 1, 1987
Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanomaT Cerny, S E Owens, S A Mackenzie, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Second IASLC Workshop on combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Treatment evaluationH Hansen, M Perry, R Arriagada, et al.
Pageof 29

Showing results (211-220 of 289) with videos related to

Sort By:
Pageof 29
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Viridans streptococcal bacteraemia in patients with haematological and solid malignanciesA D Burden, B A Oppenheim, D Crowther, et al.
Melanoma Research|April 4, 2002
Effect of temozolomide on central nervous system relapse in patients with advanced melanomaM J Paul, Y Summers, A H Calvert, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 9, 2003
A phase II study of carboplatin and vinorelbine in patients with poor prognosis small cell lung cancerH J Mackay, M O'Brien, S Hill, et al.
Lancet (London, England)|May 8, 1982
11-week course of sequential methotrexate, thoracic irradiation, and moderate-dose cyclophosphamide for "limited"-stage small-cell bronchogenic carcinoma. A study from the Manchester Lung Tumour GroupN Thatcher, P V Barber, R D Hunter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseaseN Thatcher, H Sharma, R Harrison, et al.
Cancer Treatment Reports|April 1, 1985
Activity of JM9 in advanced ovarian cancer: a phase I-II trialV H Bramwell, D Crowther, S O'Malley, et al.
British Journal of Cancer|February 1, 1996
Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancerD C Betticher, J Heighway, P S Hasleton, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosisA G Kamthan, M J Lind, N Thatcher, et al.
European Journal of Nuclear Medicine|January 1, 1987
Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanomaT Cerny, S E Owens, S A Mackenzie, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Second IASLC Workshop on combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Treatment evaluationH Hansen, M Perry, R Arriagada, et al.
Pageof 29